share_log

Baird Maintains Neutral on Medpace Hldgs, Raises Price Target to $233

Benzinga Real-time News ·  Feb 15, 2023 07:35

Baird analyst Eric Coldwell maintains Medpace Hldgs (NASDAQ:MEDP) with a Neutral and raises the price target from $226 to $233.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment